Pharmacological blockade of the mast cell MRGPRX2 receptor supports investigation of its relevance in skin disorders

Colin H. Macphee(GlaxoSmithKline (United States)), Zining Wu(GlaxoSmithKline (United States))
Frontiers in Immunology
October 18, 2024
Cited by 19


Related Papers

No related papers found

Powered by citation graph analysis